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Exosomes are small membrane vesicles of endocytic origin. They have been 
described for the first time thirty years ago. Early research focusing on reticulocyte 
maturation and investigation of the destiny of the transferrin receptor discovered 
accumulation of transferrin receptors in multivesicular bodies and proposed the 
transferrin receptor to be externalized in 50 nm-vesicles (Harding et al. 1983; Pan 
and Johnstone 1983). These small exocytosed membrane vesicles were termed 
exosomes (Johnstone et al. 1989). For specification of usage, exosomes are defined 
by three main characteristics: a saucer-like shape and size of 40 - 100 nm as 
determined by electron microscopy, a density of 1.10 - 1.23 g/ml in a sucrose 
gradient, and the presence of certain exosomal markers including alix, tsg101, 
CD81, and flotillin. These markers belong to different protein groups involved in 
targeting, signaling, or fusion. One of the major protein groups found in exosomes 
are the so called tetraspanins like CD 81 (Mathivanan et al. 2012; Thery et al. 
2002). A new great interest on exosomes arose about ten years later, when it was 
discovered that exosomes are involved in immunological processes (Raposo et al. 
1996). Since this outstanding discovery, the role of exosomes has been addressed in 
several studies in vitro and in vivo.  
1.1.1 Production, biogenesis, and functions 
A variety of cell types produces exosomes: hematopoietic cells such as dendritic 
cells, mast cells, B and T cells (Thery et al. 2002) and also non-hematopoietic cells 
such as intestinal epithelial cells (van Niel et al. 2001), human keratinocytes 
(Chavez-Muñoz et al. 2008), and solid tumor cells (Xiao et al. 2012). Exosomes 
have even been discovered in vivo in body fluids such as blood (Caby et al. 2005), 
urine (Zhou et al. 2006), and bronchoalveolar lavage (Admyre et al. 2003). The 
biogenesis of exosomes itself has not yet been fully understood and still requires 
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further clarification regarding its details. Yet, a substantial body of evidence has 
accumulated that provides insight into the main principles of exosome biogenesis: 
Eukaryotic cells hold a highly developed endosomal network to link synthesis, 
transport, and fusion processes. Early endosomes are membrane-bound organelles 
that either gather endocytosed material from the plasma membrane or synthesized 
proteins from the Golgi complex. These early endosomes are able to transform to 
multivesicular bodies (MVB), sometimes also referred to as late endosomes or 
multivesicular endosomes, through inward budding of their membrane and forming 
small intraluminal vesicles (ILV). Evidence suggests the existence of different 
subpopulations of MVB, differing in destinations. MVB can either be directed to 
fuse with lysosomes for degradation or to fuse with the cells’ plasma membrane 
exocytosing its vesicles. These small exocytosed membrane vesicles are referred to 
as exosomes (Fig. 1).  
 
 
Figure 1: Biogenesis of exosomes.  Early endosomes transform to multivesicular bodies by inward 
budding of their membrane and forming small intraluminal vesicles. Multivesicular bodies either 
fuse with lysosomes and are degraded or they fuse with the cell membrane and exocytose their 
vesicles. These exocytosed membrane vesicles are referred to as exosomes. 
 
Due to the mechanism of emergence, exosomes contain material of the cytoplasm 
and the same membrane orientation as the cell itself, representing a cell in miniature 
format with regard to its structure and lipid bilayer (Lakkaraju and Rodriguez-
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Boulan 2008). However, exosomes can be enriched with certain cargoes in 
comparison to their mother cells and do not contain the exact same protein 
composition (Ratajczak et al. 2006). A pivotal role in the process of biogenesis has 
been ascribed to the different endosomal sorting complexes required for transport 
(ESCRT) proteins. These complexes engineer inward budding of vesicles, cluster 
marked proteins, and package those proteins into the formed ILV. Alix, often used 
as classical exosomal marker, holds a linker role between the different ESCRT 
proteins and might also be involved in the generation of intraluminal vesicles 
(Babst 2005).  
During the years following first discovery, exosomes attracted more and more 
notice. It became clear that the idea of exosomes functioning as the garbage system 
of the cell by externalizing obsolete proteins was only one of various functions. As 
exosomes contain a certain set of exosome-specific proteins, they additionally 
contain a special set of proteins depending on the cell type they originate from 
(Simpson et al. 2008). Secreted exosomes can be internalized by other cells 
(Morelli et al. 2004) and even a specific uptake and target selection has been 
suggested (Rana and Zoller 2011). Consequently, exosomes can be considered as a 
non-classical way of protein secretion and delivery and as a mediator of 
communication without direct cell-cell contact. By influencing cell-to-cell 
communication, exosomes are also able to affect and direct immune processes. 
Further, the enrichment of certain proteins in exosomes qualifies them as usable 
biomarkers for diseases like Alzheimer`s disease (Cogswell et al. 2008), Sjögren`s 
syndrome (Michael et al. 2010) and especially for certain tumor diseases, as 
exosomes are produced by a variety of tumor cells (Simpson et al. 2009). Different 
studies focusing on dendritic cell-derived exosomes established a revolutionary 
therapy option using exosomes as vaccine in immunotherapy against cancer (Viaud 
et al. 2010). Lately, different groups were able to demonstrate the transfer of 
microRNA and messengerRNA in exosomes, even broadening the understanding of 
exosomes’ functions to the possibility of genetic exchange (Valadi et al. 2007). 
Unfavorably, as exosomes deliver information and proteins to different T cells, they 
can also spread diseases by transporting infectious cargoes such as viruses or prions 
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(Fevrier et al. 2004; Nguyen et al. 2003). Besides the above-mentioned 
functions - communication, immune modulation, biomarker, immunotherapy, 
transfer of mRNA, transfer of infectious cargo - exosomes might exert additional, 
yet unknown, functions and further research will be needed for clarification. 
1.1.2 Immune functions of exosomes 
The strong interest in immunological capacities of exosomes arose in the late 
nineties with the discovery of B cells presenting antigens via their exosomes 
(Raposo et al. 1996). Subsequent research demonstrated antigen-presenting 
cell-derived (APC-derived) and tumor-derived exosomes to carry antigenic 
peptide-loaded MHC I and MHC II molecules and to induce antigen-specific T cell 
responses in vitro and in vivo (Chaput and Thery 2011; Thery et al. 2009; Zitvogel 
et al. 1998). Even though some exosomes are able to directly interact with T cells to 
elicit immune responses (van Niel et al. 2003), others depend on the presence of 
APC (Skokos et al. 2001). Further, it is believed that immature DC transfer 
processed antigen-MHC complexes via exosomes to other DC, spreading antigenic 
information and multiplying the number of effective APC (Pant et al. 2012). 
However, the way how exosomes influence immune reactions strongly depends on 
the maturation and stimulation stage of the parent cell they are derived of and the 
cell lineage itself (Viaud et al. 2010). These aspects lead either to pro-inflammatory 
responses as for example demonstrated for B cell-derived and APC-derived 
exosomes (Admyre et al. 2007; Kovar et al. 2006) or to anti-inflammatory 
responses as demonstrated for exosomes found in bronchoalveolar lavage of 
tolerized mice (Prado et al. 2008) or for exosomes derived from serum to treat 
arthritis (Yang and Robbins 2012). Since most research has been conducted with 
professional APC it will be interesting to broaden immunological aspects of 




1.2 Keratinocytes and the cutaneous immune system 
Keratinocytes, constituting the majority of epidermal cells, form a firm united 
multicellular structure, building up a barrier to environmental influences. Besides 
the physical barrier to pathogenic microbes, keratinocytes express MHC I and a 
subset of so called toll-like receptors (TLR), belonging to the group of pattern 
recognition receptors (PRRs). This kind of receptors is activated by certain 
components of microbial pathogens named pathogen-associated molecular patterns 
(PAMPs) (Mempel et al. 2007). The activation of TLRs through pathogens induces 
an intracellular cascade leading to the production of chemokines and cytokines. 
Those chemokines, in turn, recruit further immune competent cells such as 
neutrophils to eliminate invading pathogens or at least to prevent their spreading 
(Iwasaki and Medzhitov 2004). Additionally, keratinocytes form a chemical barrier 
through the production of antimicrobial lipids. By means of those antimicrobial 
peptides including defensins, cathelicidins, and RNase7, they are able to kill or 
inactivate a variety of microorganisms (Pivarcsi et al. 2005) (Fig. 2).  
 
 
Figure 2: Keratinocytes are an integral component of the cutanous immune system.  
Keratinocytes express MHC I and a subset of toll-like receptors. Through activation of these 
receptors, keratinocytes produce different chemokines to recruit immune competent cells. Further, 




Besides the pivotal role of keratinocytes for cutaneous innate immunity, an 
important contribution to adaptive immune responses is discussed. Keratinocytes 
constitutively express MHC I but no MHC II. However, inflammatory conditions 
(IFNγ) induce keratinocytes to express MHC II and to function as so called 
non-professional APC, providing co-stimulatory signals to T cells (Nickoloff and 
Turka 1994). These findings are supported by the discovery that keratinocytes 
function as accessory APC in vitro and in vivo irrespective of the presence or 
absence of professional APC (Kim et al. 2009). Moreover, it has been shown that 
keratinocytes are able to take up antigen, to efficiently process it, and to present it to 
CD4-positive and CD8-positive memory T cells, thus inducing an immune response 




1.3 Adaptive immune response 
Keratinocytes accomplish a main task of the cutaneous innate immunity. With the 
discovery of keratinocytes functioning as non-professional APC, research started to 
focus on their ability to direct adaptive immune responses. Classically adaptive 
immune responses are induced by professional APC. In the skin, Langerhans cells 
fulfill this task (Banchereau and Steinman 1998). Immature dendritic cells have a 
high phagocytotic activity, thus they efficiently internalize antigen. Uptake of 
antigen leads to maturation, lowers phagocytotic activity, and increases the 
expression of co-stimulatory molecules such as CD40 or CD86. The internalized 
antigen is processed and presented mainly via MHC II to CD4-positive T cells but 
also by cross-presentation via MHC I to CD8-positive T cells, inducing an antigen-
specific T cell response (Mellman and Steinman 2001) (Fig. 3).  
 
 
Figure 3: Overview of an adaptive immune response.  APC take up antigen, process it, and 
present it via MHC II to CD4-positive T cells or as cross-presentation via MHC I to CD8-positive 
T cells, inducing and antigen-specific T cell response.  
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2 Aim of this study 
Research into the (patho)-physiology of exosomes has focused primarily on 
exosomes derived from hematopoetic cells (Thery et al. 2002). Hence, data on 
exosomes of epithelial cells such as keratinocytes are scant (Chavez-Muñoz et al. 
2008; Chavez-Muñoz et al. 2009; Sanderson et al. 2008). The aim of this study was 
to explore keratinocyte-derived exosomes as a new mechanism for keratinocytes to 
influence immunity. As keratinocytes are organized in a firm polarized epithelial 
tissue structure, they only have a close range to present antigen to other cells when 
acting as non-professional APC. To expand their range of communication with 
other cells, keratinocyte-derived exosomes could serve as an additional mechanism 
to spread antigenic information to certain cells beyond their immediate reach. 
Experimental evidence suggests that the uptake of exosomes is a non-random event 
influenced by the presence of certain tetraspanins as uptake selection markers (Rana 
and Zoller 2011). Consequentely, keratinocytes could take up antigen and transfer it 
to their exosomes. These antigen-loaded exosomes could be taken up by dendritic 
cells and influence their cytokine profile or maturation state. Further, 
antigen-containing exosomes internalized by dendritic cells could be presented to 
antigen-specific T cells and elicit antigen-specific proliferation (Fig. 4).  
 
 
Figure 4: Hypothetic role of keratinocyte-derived exosomes in immune responses. 
Keratinocytes take up antigen and transfer it to their exosomes. These antigen-containing exosomes 
then become internalized by dendritic cells and elicit an antigen-specific T cell response when 
presented. 
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In reverse, to address the mutual influence of exosomes and their environment, the  
influence of  environmental conditions on exosome composition should also be 
explored. As frequent chronic diseases, the pathologically altered cytokine 
environments in psoriasis and atopic dermatitis appear suitable for this investigation 
(Bieber 2012; Raychaudhuri 2012). Toward this end, the follwing questions should 
be answered to address the immunlogical role of keratinocyte-derived exosomes: 
 Do keratinocytes transfer internalized antigen to their exosomes? 
 Do these exosomes influence the maturation state and interleukin profile of bone 
marrow-derived dendritic cells (BMDC)? 
 Are antigen-containing exosomes able to elicit an antigen-specific T cell 
response via BMDC? 
 Do environmental conditions influence the composition of keratinocyte derived 
exosomes? 
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3 Material and Methods 
3.1 Material 
3.1.1 Laboratory equipment 
Table 1: Laboratory equipment 
Laboratory equipment Company 
Appliskan Multimode Microplate Reader Thermo Scientific 
Autoclave Sanyo  
BD FACSCanto II BD Bioscience 
Beckman optima LE 30K ultracentrifuge Beckman Coulter GmbH 
bucket rotor Sw 32Ti Beckman Coulter GmbH 
Centrifuge Multifuge 15-R Heraeus 
Centrifuge Pico 17 Heraeus 
Centrifuge Rotina 35 Hettich Zentrifugen 
CM120 electron microscope Philips 
CO2 incubator HERAcell 150i Thermo Scientific 
Confocal  microscope  Olympus Fluoview 1000, 
System Version 3.1.1.9 
Olympus 
Copper grid Plano 
Cytospin 2 centrifuge Shandon 
Double distilled water system arium® 611VF Sartorius 
Electrophoresis Power Supply-EPS 1001 Amersham Biosciences 
Heating block Thermo Stat plus Eppendorf 
Incubator HERAcell 150 
 
Thermo Scientific 




LAS-4000 imaging system Fujifilm 
LTY Orbitrab XL hybrid mass spectrometer Thermo Scientific 
MACS MultiStand Miltenyi 
MidiMACS Separator Miltenyi 
Magnet stirrer VWR 
Micro scale ALC Acculab 
Microcentrifuge Sprout 
Microscope Axio Imager M1 Zeiss 
Microscope Axiovert 40 Zeiss 
Nanoflow LC system Agilent  
Neubauer counting chamber Brand 
pH-meter FE20-Five easyTM Mettler Toledo 
Photometer Genesys 10 Bio Thermo Scientific 
Pipetboy acu IBS Integra Biosciences 
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Pipette set: 1000, 100, and 10 μl Eppendorf 
PowerPac Basic Bio-Rad 
Refrigerated centrifuge  Eppendorf 
Refrigerator and freezer +4°C, -20°C, -80°C 
R 
Liebherr 
Roborack-96  Micronic 
oborack-96  cover Micronic 
Rocking platform Polymax 1040 Heidolph 
Scale precision Sartorius 
Scale Vicon  Acculab 
Shaker  Grant-bio 
See-saw rocker SSL4 Stuart 
Sonorex RK 100 Transistor Bandelin 
Spectrometer Genesys 10Bio Thermo Scientific 
Sterile bench HERAsafe Thermo Scientific 
Sterile bench Safe 2020 Thermo Scientific 
Thermal mixer ThermoStat plus Eppendorf 
Trans –Blot SD semi-dry transfer cell Bio-Rad 
Vacusafe comfort IBS Integra Biosciences 
Vertical electrophoresis system Mini-
PROTEAN®TetraCell  
Bio-Rad 
Vortex L46 Labinco 






Table 2: Disposables 
Disposable/ Material Company 
6-well plates Greiner Bio One 
8-well CultureSlides BD Bioscience 
96-well plates U bottom Nunc 
Cell culture flasks 175 cm³ Sarstedt 
Cell strainer 70 µm BD Bioscience 
Chromatography paper Whatman™ GE Healthcare 
Cover glasses, 24x 60 mm Menzel-Gläser 
FACS tubes 5 ml BD Bioscience 
Eppendorf tubes 0.5 ml, 1.5 ml, 2.0 ml Eppendorf 
Falcon tubes 15 ml, 50 ml Greiner Bio-One 
Filter V50 0,2µm Sarstedt  
Macs LS Columns Miltenyi 
Needle Microlance 3 BD Bioscience 
Nitrocellulose membrane Bio-Rad 
Nunc® Sealing tape for multiwell plates Sigma-Aldrich 
Perfusor® syringe, 50 ml B. Braun 
Petri dish 35 x 10 Nunc 
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Pipette tips 1000, 200, and 10 μl Starlab 
Plastic pipettes 25 ml, 10 ml, 5 ml Sarstedt 
Plastic cuvettes Sarstedt 
Polypropylene tubes, 1.3 ml Greiner 
Pre-separation filters 30 µm Miltenyi 
Reaction cups 2 ml, 1.5 ml and 0.5 ml Eppendorf 
Syringe 1 ml Omnifix 40 solo B. Braun 
TechnoCut scalpel HMD Healthcare 
Tube, round bottom, 1.3 ml Greiner 
Tube, thinwall, ultra clear 38.5 ml Beckman Coulter 
UpCell Surface cell culture dish 92 x 17 mm Nunc 
3.1.3 Reagents 
Table 3: Reagents 
Reagent Company 
4’,6-diamidino-2-phenylindole (DAPI) Sigma-Aldrich 
7x Protease inhibitor cocktail Roche 
Acetic acid Merck 
Acetone Roth 
Acrylamide/ Bis-acrylamide, 30 % solution Bio-Rad 
Ammonium chloride Merk 
Ammonium persulfate Gibco  
BGG protein standards 0.125 – 1.5 mg/ml Fermentas 
Bio-Rad protein assay dye Bio-Rad 
Boric acid Roth 
Bovine serum albumin Roth 
Bradford Reagent Bio-Rad 
Bromophenol blue Sigma-Aldrich 
BSA Standards, ready to use Fermentas 
Calcium chloride (CaCl2) Roth 
CFDA-SE Invitrogen 
Citric acid Roth 
Coomassie Brilliant Blue (triphenylmethane) Bio-Rad 
D(+) saccharose  Roth 
DMSO (Dimethyl sulfoxide) Sigma-Aldrich 
DTT (Dithiothreitol) Roth 
Ethanol Roth 
EDTA (Ethylenediaminetetraacetic acid) Roth 
FACS Clean solution BD Bioscience 
FACS Shutdown Solution BD Bioscience 
Fluorescence Mounting Medium Dako 
Glycine Merck 
Glutaraldehyde Electron Microscopy Science 
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Hydrochloric acid (HCl) Roth 
Hydrogen peroxide (H2O2) Roth 
IAA (indole-3-acetic acid) Sigma 
Luminol Sigma 
Magnesium chloride (MgCl2) Merck 
Methanol Merck 
Non-fat dry milk (NFDM) Bio-Rad 
NP-40 USB 
NuPAGE Bis-Tris Gel 4-12% Invitrogen 
Ovalbumin grade V Sigma 
Ovalbumin purified Worthington 
Ovalbumin conjugate FITC Molecular probes 
p-Coumaric acid Sigma 
Paraformaldehyde Roth 
Ponceau S Sigma-Aldrich 
Potassium chloride (KCl) Roth 
Potassium hydroxide (KOH) Merck 
Potassium dihydrogen phosphate (KH2PO4) Merck 
Propidium iodide Roth 
Restore Western Blot Stripping Buffer Thermo Scientific 
Sodium azide (NaN3) Merck 
Sodium chloride (NaCl) Merck 
Sodium hydrogen carbonate Roth 
Sodium hydrogen phosphate Roth 
Sodium n-dodecyl sulfate (SDS) Calbiochem 
Stripping buffer Thermo Scientific 
Sulfuric acid (H2SO4) Roth 
Tetramethylethylbenzidine (TMB) Roth 
Tetramethylethylenediamine (TEMED) Merck 
TRIS Roth 
TRIS-HCl Roth 
Triton X-100 Merck 
Trypan blue Sigma 
Trypsin-EDTA 0.05%/0.02% Roth 
Trypsin-Inhibitor  
Tween-20 Roth 
Uranyl acetate Sigma 
3.1.4 Enzymes 
Table 4: Enzymes 
Enzym Company 
Collagenase D Roche 
DNAse Roche 
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3.1.5 Cytokines 
Table 5: Cytokines 
Cytokine Concentration used Company 
IFNγ 50 ng/ml BioLegend 
IL-2 10 ng/ml BioLegend 
IL-4 10 ng/ml BioLegend 
IL-13 50 ng/ml Immunotools 
IL-17 10 ng/ml Immunotools 
IL-22 50 ng/ml BioLegend 
TNFα 25 ng/ml Immunotools 
3.1.6 Antibodies directed against murine antigens 
Table 6: Antibodies 
Antibody Concentration used Company 
CD3ε 1 µg/ml eBioscience 
CD4 (L3T4), MicroBeads 10 µl/107cells Miltenyi 
CD8a (Ly-2), Micro Beads 10 µl/107cells Miltenyi 
CD28 1 µg/ml eBioscience 
 
Antibodies used in flow cytometry, fluorescence and confocal microscopy, and 
Western blot are stated within the corresponding section. 
3.1.7 Size markers 
Table 7: Size markers 
Size marker Company 
PageRuler Prestained Protein Ladder Thermo Scientific 
3.1.8 Software 
Table 8: Software 
Program Company 
3 D -Software Imaris Bitplane Version 7.40 Bitplane 
Adobe Illustrator Adobe 
Axiovision Rel 4.7 Zeiss 
FACS DIVA software BD Bioscience 
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LAS2000 Imaging System Fujifilm 
Multi Gauge V3.2 Fujifilm 
Metamorph 6.3r2 Molecular Devices 
Microsoft Office 2007 Microsoft 





3.1.9 Commercial kits 
Table 9: Commercial kits 
Commercial kit Application Company 
PKH-linker kit fluorescent cell labeling 
 
Sigma-Aldrich 
murine ELISA kits: IFNγ, IL-6, IL-10, 
IL-12 p70 
chemokines measurement BioLegend 
3.1.10 Buffers and solutions 
Digest buffer (50 ml) 
 
0.5 ml 
1 M 2-(4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid  
5 ml 1.5 M NaCl  
0.5 ml  500 mM KCl  
0.5 ml 100 mM MgCl2 
0.5 ml 200 mM  Ca Cl2 
ad 50 ml aqua  
0.25 ml 1% DNAse  
0.25 ml 10 mg/ml collagenase D 
  ECL 1 (10 ml) 
 1 ml 1 M Tris-HCl pH 8.5 
9 ml aqua 
45 µl 90 mM coumaric acid 
100 µl 250 mM luminol 
 
ECL 2 (10 ml) 
1 ml 1 M Tris-HCl pH 8.5 
9 ml aqua 
6 µl 30% hydrogen peroxide 
  Erythrocyte lysis buffer 10x (1 l) 
 80.2 g NH4Cl  
8.4 g NaHCO3  
20 ml 0.5 M EDTA  pH 8,0   
ad 1 l aqua  
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  MACS buffer (500 ml) 
 495.5 ml  PBS 
2.5 ml FCS 
2 ml 0.5 M EDTA  pH 8.0   
  PBS 10x (5 l) 
 400 g  NaCl 
10 g KCl 
72 g Na2HPO4 x 2H20 
10 g KH2PO4 
ad 5 l aqua 
adjust pH to 7.2  
  Ponceau-S staining solution (50 ml) 
 50 mg Ponceau-S 
2.5 ml acetic acid 
ad 50 ml aqua 
  Protein lysis buffer (20 ml) 
 200 µl 1 M Tris-HCl pH 7,0 




ad 20 ml aqua 
1x protease inhibitor cocktail  
  Running buffer 10x (2 l) 
 288 g glycine 
60 g tris 
100 ml  10% SDS solution 
ad 2 l aqua 
  Substrate buffer  (11 ml) 
 10,89 ml 200 mM citric acid monohydrate 
110 µl 30% hydrogen peroxide 
5,1 µl  tetramethylbenzidine (TMB) 
  TBS-T  (1 l) 
 10 ml 1 M TRIS/HCl pH 7,0 
2 ml    0.5 M EDTA pH 8 
50 ml    NaCl 
500 µl Tween 20 (T) 




Material and Methods 17 
 
  Transfer buffer (1 l) 
 2.93 g glycine 
5.82 g    tris 
3.75 ml    10% SDS solution 
200 ml methanol 
ad 1 l aqua 
3.1.11 Cell culture reagents and media 
Table 10: Cell culture reagents and media 
Reagents Company 
β-mercaptoethanol Sigma-Aldrich 
FCS (fetal calf serum) PAA 







non-essential amino acid Invitrogen 
 
PBS (phosphate buffered saline) PAA 
PCT Epidermal Keratinocyte Medium,  CnT-07 CellnTec 
Penicillin/ streptomycin (100x) Invitrogen 





BMDC culture medium (500 ml)  
440 ml RMPI 1640 with L-glutamine  
500 µl  50 mM β-mercaptoethanol  
50 ml  fetal calf serum (FCS)  
5 ml 200 mM L-glutamine  
5 ml 100 U penicillin + 100 µg/ml streptomycin  
  T cell culture medium (500 ml)  
476 ml BMDC culture medium 
12.5 ml 
1 M 2-(4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid  
5.6 ml 100 mM non-essential amino acid (Invitrogen) 




MPEK culture medium  (500 ml) 
 500 ml PCT Epidermal Keratinocyte Medium, CnT-07  
1x supplement A  
1x supplement B  
1x supplement C  
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3.1.12 Animals 
Table 11: Animals 
Mouse Company 
C57BL/6  Charles River Laboratories 
OT-I Jackson Laboratory 
OT-II  Jackson Laboratory 
3.1.13 Long-term culture cells 
Table 12: Long-term culture cells 
Cell line Company 
murine epidermal keratinocyte progenitor cell line MPEK-BL6 CellnTec 
3.2 Methods 
3.2.1 Animals 
Primary cells were isolated from C57BL/6, OT-I, or OT-II mice, respectively. 
Experiments were conducted according to the guidelines of the respective authority 
(LAVES, Niedersächsisches Landesamt für Verbraucherschutz und 
Lebensmittelsicherheit). Mice were raised in the animal facility of the University 
Medical Center Göttingen under high hygienic levels, 12 h/12 h day/night cycle, 
and according to the natural needs of the species with food and water ad libitum.  
3.2.2 Cell culture (primary and long term) 
Cells were cultured under sterile conditions at 37°C, 5% CO2, and 95% humidity. 
For long-term culture, the murine keratinocyte cell line MPEK-BL6 was used. As 
primary cells bone marrow-derived dendritic cells and CD4- and CD8-positive 
T cells were isolated.  
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3.2.2.1 Bone marrow–derived dendritic cells (BMDC) 
Generation of BMDC was accomplished as described previously (Braun et al. 2010; 
Lutz et al. 1999). On day 0, bone marrow of tibia and femur from C57Bl/6 mice 
was rinsed out and cell suspension was collected. Erythrocytes were removed using 
erythrocyte lysis buffer for 7 min at room temperature. The remaining cells were 
washed twice with medium and counted with the help of a Neubauer counting 
chamber using trypan blue exclusion to determine cell viability. 2 x 10
6 
of gained 
cells were sewed per tissue culture dish with 10 ml of BMDC culture medium in the 
presence of 10% (vol/vol) murine granulocyte macrophage colony-stimulating 
factor (GM-CSF)-containing supernatant. GM-CSF derived from a murine 
GM-CSF clone (hypoxanthine-aminopterin-thymidine-sensitive Ag8653 myeloma 
cell line transfected with murine GM-CSF cDNA isolated from a T cell clone by 
PCR and inserted into the vector BCMGSNeo) (Zal et al. 1994). On day 3 and 6, 
culture medium and GM-CSF were additionally added or used for replacement, 
respectively, to a total volume of 20 ml culture medium containing 10% (vol/vol) 
GM-CSF. On day 8, generation of BMDC was completed and non-adherent and 
loosely adherent cells, corresponding to the generated population of BMDC, were 
harvested and subjected to further experiments. Generated BMDC were considered 
as semi-mature. 
3.2.2.2 Purification of CD4- and CD8-positive T cells 
To assess the antigen-specific immunostimulatory potential of exosomes, CD4- and 
CD8-positive T cells from transgenic mice (OT-I and OT-II, respectively), 
expressing an OVA specific T cell receptor, were used. For T cell purification, 
spleen and axial, brachial, and inguinal lymph nodes were mechanically and 
chemically prepared. Shortly, spleen cells were passed through a 70 µm cell 
strainer, the cell suspension was depleted of erythrocytes using erythrocyte lysis 
buffer for 7 min at room temperature, and cells were washed in MACS buffer. 
Lymph nodes were chemical digested with digest buffer for 30 min at 37°C. 
Afterwards, cells were washed and CD4- and CD8-positive T cells of spleen and 
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lymph nodes were enriched using specific antibody-coated magnetic microbeads. 
The principle used was based on positive magnetic sorting (MACS). Desired cell 
population was labeled with magnetic antibodies. For labeling 90 µl of MACS 
buffer per 10
7
 cells were incubated with 10 µl either CD4-or CD8a-specific micro 
beads per 10
7
 cells for 15 min at 4°C in the dark. Suspension was washed with 1 ml 
MACS buffer per 10
7
 cells. Cells were pelleted and collected in 1 ml of degassed 
MACS buffer. A separation column was attached to a magnet and rinsed with 1 ml 
of degassed MACS buffer. Afterwards, cell suspension was given through the 
column and the magnetic labeled cells were caught within the column whereas all 
other cells were rinsed out with 9 ml of MACS buffer and collected as negative 
population. Removal of the column from the magnet and rinsing of the column 
freed positive cells. CD4- and CD-8 positive T cells, respectively, were counted 
with the aid of a Neubauer counting chamber using trypan blue dye to determine 
cell viability. 
3.2.2.3 Long term culture 
The murine epidermal keratinocyte progenitor cell line MPEK-BL6 was cultivated 
in serum-free keratinocyte medium. Cells were cultivated in 175 cm² culture flasks 
and passaged when a confluence of 80-90% was reached to avoid differentiation of 
cells. For harvesting MPEK were washed with PBS and incubated with 5 ml 
0.05%/0.02% trypsin-EDTA for 19 min at 37°C. To end the reaction, 5 ml 
1% trypsin-inhibitor were added. MPEK were washed, pelleted and counted using a 
Neubauer counting chamber and trypan blue exclusion to determine cell viability.  
Keratinocytes were seeded at a density of 4.6-8.6 x 10³ cells/cm
2 
depending on the 
following experiments.  
To demonstrate antigen uptake by MPEK, the model antigen OVA was used. Cells 
were incubated for 24 h with 10 µg/ml or 20 µg/ml of FITC labeled OVA. To 
distinguish between nonspecific attachment and active antigen uptake, cells were 
either incubated at 4°C or at 37°C, respectively. Analysis of fluorescence intensity 
was conducted by flow cytometry and immunofluorescence.  
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For exosome purification, MPEK were seeded at a density of 4.6 x 10³ cells/cm
2 
and cultured for a total of 96 h. Within the first 48 h, cells were incubated with or 
without 1 mg/ml OVA. To remove residual OVA from the supernatant, cells were 
then washed extensively with PBS. Thereafter, cells were stimulated for 48 h with 
or without 50 ng/ml IFNγ, or with 10 ng/ml IL-4 and 50 ng/ml IL-13, or with 
10 ng/ml IL-17, 50 ng/ml IL-22, and 25 ng/ml TNFα. Afterwards, supernatant of 
MPEK was collected to purify exosomes, and MPEK were lysed for Western blot 
analysis. The different steps of incubation and stimulation described led to six 
different conditions as summarized in table 13. Differently generated exosomes 
were used for analysis and functional experiments.  
Table 13: Conditions for exosome generation 
0-24 h 24-48 h 
+ medium + medium 
+ medium + IFNγ 
+ OVA + medium 
+ OVA  + IFNγ 
+ medium + IL-4 IL-13 
+ medium + IL-17, IL-22, TNFα 
3.2.3 Exosome purification  
To purify exosomes, cell culture supernatant of MPEK, raised under different 
conditions as described above, was collected. To remove remaining cells, 
supernatant was centrifuged at 2,000 x g. To eliminate cell debris, the supernatant 
was transferred to ultracentrifugation tubes and centrifuged at 10,000 x g. To 
remove further impurities, the supernatant was filtrated through a 0.2 µm pore filter 
and exosomes were pelleted at 100,000 x g for 2.5 h. The invisible pellet was either 
collected in 50 µl PBS per tube for the following experiments or lysed with NP40 
containing lysis buffer for Western blot analysis. All ultracentrifugation steps were 
carried out at 4°C. 
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3.2.3.1 Density analysis of MPEK-derived membrane vesicles 
To assess whether MPEK-derived membrane vesicles had a compatible density for 
exosomes, vesicles were layered on a continuous sucrose gradient. This method 
allows to separate membrane vesicles according to their density (Thery et al. 2006). 
The used gradient consisted of eight fractions carefully overlaid with 2.5-0.5 M 
sucrose in 20 mM HEPES. Membrane vesicles pelleted at 100,000 x g were 
collected in PBS and added upon the lightest fraction. Gradients were centrifuged 
for 15 h at 100,000 x g using a swinging bucket rotor. Thereafter, each fraction was 
diluted 1:8 in PBS and centrifuged again at 100,000 x g for 1 h. Pelleted membrane 
vesicles were collected in NP40 containing lysis buffer and subjected to Western 
blot analysis.  
3.2.3.2 Fluorescence labeling of exosomes  
To visualize aggregates of exosomes in fluorescence microscopy, exosomes were 
stained with lipophilic dye using a commercial linker kit for general membrane 
labeling. 100 µl of the exosome suspension were diluted in 900 µl Diluent C and 
mixed carefully. 1 µМ PKH26 was added and exosomes were incubated for 5 min 
at room temperature. The reaction was stopped using 200 µl of exosome-free FCS. 
Afterwards, exosomal suspensions were pooled and diluted 1:6 in PBS to clear 
exosomes from redundant dye to avoid unspecific overspill. Exosomes were 
pelleted at 100,000 x g for 1 h. 
3.2.4 Functional experiments 
3.2.4.1 Co-culture of BMDC and exosomes 
Generated BMDC were harvested on day 8 and extensively washed with culture 
medium containing exosome-depleted FCS. 2 × 10
6
 cells per well of a six well 
culture dish were incubated in 2 ml exosome-depleted medium with 10 µg/ml 
MPEK-derived exosomes. BMDC were incubated with PKH26-labeled exosomes 
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to visualize exosome-uptake in a time series using immunofluorescence microscopy 
and flow cytometry. Cells were harvested after 0.5 h, 4 h, and 24 h.  
For analysis of exosomes’ impact on BMDC phenotype and interleukin profile, 
cells were incubated for 24 h with 10 µg/ml of non-labeled exosomes. Thereafter, 
BMDC were subjected to flow cytometry for phenotype analysis, and supernatant 
was collected for ELISA-based measurement of interleukin production. To 
determine if exosomes generated under various conditions differ regarding their 
impact on BMDC, the effect of different kinds of exosomes 
(Exo +/- OVA +/- IFNγ) on BMDC was analyzed. OVA-incubated (100 µg/ml) and 
medium only incubated BMDC served as controls.  
3.2.4.2 T cell proliferation assay 




T cells were labeled with CFDA-SE. 
Intracellular; CFDA-SE is converted to the fluorophore CFSE. As CFSE binds to 
intracellular molecules and is present within the cytoplasm, every cell division will 
halve CFSE fluorescence intensity. T cells were incubated in 2.5 µM CFSE in PBS 
for 8 min at 37°C in the dark, followed by two washing steps with T cell medium to 
remove residual dye. 1 x 10
5
 T cells in 200 µl medium were co-cultured in 96-well 
plates with either exosomes (10 µg/ml) or with exosome-pretreated BMDC in 
different T cell:BMDC ratios of  3:1, 10:1, or 30:1. Culture medium was used with 
or without IL-2 (10 ng/ml) as additional survival factor. Medium-incubated T cells 
and medium-incubated BMDC served as negative controls. T cells stimulated with 
CD3ε- and CD28-directed antibodies (1 µg/ml, respectively) and OVA-pretreated 
BMDC served as positive controls. After 72 h of co-incubation, cells were collected 
and measured by flow cytometry for CFSE intensity and supernatant was assessed 
by ELISA for IFNγ production. 
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3.2.5 ELISA 
Cytokine production was quantified by a sandwich ELISA. Cell culture supernatant 
of BMDC or T cells was collected and measured for murine IL-6, IL-10, IL-12p70, 
or IFNγ, respectively, as recommended by the manufacturer. Briefly, on the first 
day 96-well plates were coated with 100 µl/well capture antibody dissolved in 
either coating buffer A as provided within the kit or with regard to IL-10 in 
200 mM sodium dihydrogen phosphate. Plates were sealed and incubated at 4°C 
over night. After plates had been washed in 0.005% Tween in PBS, wells were 
incubated for 2 h at room temperature with 200 µl/well blocking buffer to prevent 
unspecific bindings. After three washing steps in 0.005% Tween in PBS, triplets of 
100 µl per sample were loaded onto the different wells. Dilution of samples had 
been determined experimentally. Standard proteins as references to extrapolate 
concentration of chemokines were used as described by the company. After 2 h of 
incubation and three following washing steps in 0.005% Tween in PBS, plates were 
incubated for 1 h with 100 µl/well of detection antibody. Afterwards, plates were 
washed again as described above and avidin-horseradish peroxidase (HRP) was 
given to the samples for 30 min followed by five washing steps in 0.005% Tween in 
PBS. Subsequent 100 µl/well substrate buffer were added. Incubation was carried 
out in the dark, the duration depended onto the chemokines and lasted between 
5 min (IL-6) and 15 min (IL-10). To end the reaction, 2 M sulfuric acid was added. 
The color change was measured at 450 nm in an Appliskan micro plate reader. To 
assure equal distribution of different solutions, plates were put onto a shaker during 
incubation.  
3.2.6 Flow cytometry 
Flow cytometry allows differentiation between cells due to their refraction of light. 
Additionally, cells can be labeled with fluorescence-coupled antibodies to analyze 
expression of proteins. Cells were harvested, washed in PBS, and pipetted into the 
tubes. 500,000 BMDC or MPEK and 100,000 T cells, respectively, were used per 
tube. To exclude unspecific binding, cells were washed in PBS and incubated with 
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10 µl anti-CD16/CD32 per sample for 10 min at 4°C. Thereafter, cells were stained 
with 10 µl of the desired antibody or the corresponding isotype control for 30 min 
at 4°C (for concentrations compare tab. 14), followed by another washing step. 
Immediately prior to measurement, 10 µl of 50 µg/ml propidium iodide (PI) were 
added to each sample to determine cell viability. Cells were analyzed with a FACS 
Canto II and the FACS DIVA software. Analysis of MPEK in flow cytometry could 
be accomplished without previous staining since OVA was directly labeled with 
FITC. In this case only additional staining with PI was accomplished. Phenotypic 
characterization of BMDC surface markers was performed on day nine with the 
following antibodies: CD11c, CD40, CD86, MHC I, and MHC II. When uptake of 
exosomes was analyzed, all markers except MHC I were measured. The 
phycoerythrin (PE) filter was suitable for PKH26 measurement for PKH-labeled 
exosomes. Analysis of T cells after co-culture with BMDC was conducted with 
antibodies directed against the following antigens: CD11c and CD4 or CD8a.  
Table 14: Antibodies used in FACS  
Antibody Clone Concentration used Fluorophore 
CD4 GK1.5 2 µg/ml PE/Cy7 
CD8a 53-6.7 2 µg/ml PE/Cy7 
CD11c N418 2 µg/ml APC/Cy7 
CD16/CD32 2.4G2 5 µg/ml purified 
 
CD40 3/23 4 µg/ml APC 
CD86 GL-1 1 µg/ml PE/Cy7 
MHC I (H-2Kb) AF6-88.5 2 µg/ml PE 
MHC II (I-A/I-E) M5/114.152 5 µg/ml FITC 
With regard to all experiments, corresponding isotype controls were purchased from 
the same manufacturer and handled in the same manner as the specific antibodies 
(all BioLegend with the exception of anti-CD16/CD32 being purchased from BD 
Bioscience). 
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3.2.7 Microscopy 
3.2.7.1 Fluorescence microscopy 
For fluorescence microscopy analysis, MPEK were plated onto chamber slides and 
cultivated for 48 h followed by 24 h of incubation with 20 µg/ml FITC-labeled 
OVA. Incubation was carried out at different temperatures to differentiate between 
unspecific binding at 4°C and active antigen uptake at 37°C. Following, cells were 
extensively washed in PBS and fixed with ice-cold methanol for 10 min. BMDC, 
incubated with 10 µg/ml PKH-labeld exosomes for 24 h, were harvested, washed 
and prepared as cytospin preparation with a density of 50,000 cells/slide. Briefly, 
100 µl of BMDC (500,000 cells/ml) were added per sample and centrifuged in 
cytospin for 10 min at 800 rpm. Dried slides were fixed in ice-cold methanol and let 
dry again. BMDC as well as MPEK were covered with Fluorescence Mounting 
Medium supplemented with 0.5 µg/ml DAPI for nuclear staining. An Axiovert 40 C 
microscope and AxioVision 4.7 software were used for image acquisition. 
3.2.7.2 Confocal microscopy 
To confirm OVA uptake by MPEK, confocal images were acquired. MPEK were 
cultivated in chamber slides and incubated with medium or purified OVA 
(1 mg/ml) for 24 h. For membrane labeling, cells were incubated for 10 min at 37°C 
with 300 µl/chamber of 3.3 µg/ml wheat germ agglutinin (WGA) Alexa Fluor 633 
conjugate in HBSS. WGA labels membranes by selective binding to 
N-acetylglucosamine and N-acetylneuraminic acid residues (Wright 1984). After 
five washing steps with HBSS, keratinocytes were fixed in 4% PFA for 15 min at 
4°C and were washed again in HBSS. To prevent antibodies from unspecific 
binding, samples were incubated with 5% FCS in PBS for 1 h. To facilitate 
penetration of antibodies through cell membranes, the blocking solution also 
contained 0.2% of Triton X to increase permeability. Anti-ovalbumin in 2.5% FCS 
served as primary antibody. Incubation was carried out overnight at 4°C. 
Afterwards, samples were extensively washed with PBS over 30 min before 
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incubation with secondary antibody in 2.5% FCS was conducted for 1 h at room 
temperature, followed by multiple washing steps in PBS. Samples were covered 
with Fluorescence Mounting Medium supplemented with 0.5 µg/ml DAPI for 
nuclear staining. Analysis was carried out with an Olympus Fluoview 1000 and the 
help of Dr. J. Wessels and J. Mahrt (MOLCI (Molecular and Live Cell Imaging 
service facility), University Medical Center Göttingen). 
Table 15: Antibodies used in confocal microscopy 
Antibody/ Lectin Host 
species 
Concentration used Fluorophore Manufacturer 
ovalbumin mous         1 µg/ml purified Biozol 
mouse goat     2.5 µg/ml Alexa Fluor 488 Cell Signaling 
WGA --     3.3 µg/ml Alexa Fluor 633 Invitrogen 
3.2.7.3 Electron microscopy 
Due to the size of exosomes of 50-100 nm (Thery et al. 2009), electron microscopy 
is necessary to visualize the vesicles. For analysis, the drop-to-drop method was 
used. Briefly, a carbon-coated 400-mesh copper grid was positioned on a drop of a 
liquid specimen to absorb for 1 min; excess fluid was carefully removed with filter 
paper. Following, the grid was placed within a large drop of 1% glutaraldehyde to 
absorb for 1 min, and excess fluid was once again removed. After washing in 5 
drops of dH2O, staining with 1% uranyl acetate for 30 sec was performed. The dried 
grid was examined with a CM120 electron microscope and images were recorded 
using an iTEM-Camera. D. Wenzel, Electron Microscopy Group, Max Planck 
Institute for Biophysical Chemistry, Göttingen, carried out preparation of samples 
and microscopy.  
3.2.8 Protein analysis 
3.2.8.1 Bradford assay 
Proteins were quantified using Bradford assays. Coomassie Brilliant Blue binds to 
the present protein in the particular sample, the formed protein complex leads to a 
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change of the absorption maximum from 465 nm to 595 nm that can be measured 
photometrically. Before analysis, samples were prepared as follows: MPEK and 
spleen cells, purified as described in “Purification of CD4- and CD8-positive 
T cells” (page 19), were lysed with the appropriate amount of lysis buffer, 
mechanically homogenized, and lysates were centrifuged. The supernatant was 
analyzed further and the pellet was discarded. Exosomes resuspended in lysis buffer 
were subjected to Bradford assays. One blank and six samples with defined protein 
amounts were used to generate a standard concentration graph. Samples were 
prepared as follows: 
800 µl aqua dest. 
1 µl lysat 
200 µl   color reagent BioRad Protein Assay  
1 ml   sample  
Samples were vortexed and measurement was accomplished with a spectrometer at 
595 nm within 5 min to 1 h due to samples’ stability in that time period. 
3.2.8.2 SDS-Page and Western blot  
Before samples were loaded onto a 10% acrylamide gel and subjected to 
SDS-PAGE analysis, 5x SDS sample buffer and 1 M DTT were added with final 
concentrations of 1x and 50 mM, respectively. Equal protein amounts were loaded 
onto the gel.  
1x stacking gel   1x separation gel 10% 
1.55 ml aqua bidest.  2 ml aqua bidest. 
0.25 ml 30% acrylamide mix  1.65 ml 30% acrylamide mix 
0.19 ml 1 M Tris HCl pH 6.8  1.25 ml 1.5 M Tris HCl pH 8.8 
15 µl 10% SDS   50 µl 10% SDS 
15 µl 10% APS  50 µl 10% APS 
1.5 µl TEMED     7.5 µl TEMED 
A prestained protein ladder (5 µl) was used as size marker. Samples were separated 
at 200 V with the usage of 1x running buffer until the dye reached the lower 
boarder of the gel. Using the procedure of semi dry blot and transfer buffer for 
40 min at 150 mA, samples were transferred to a nitrocellulose membrane. 
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Successful transfer of proteins was controlled by membrane staining with 
Ponceau-S. To prevent antibodies from unspecific binding, the membrane was 
blocked for 1 h at room temperature with 5% non-fat-dry-milk (NFDM) in TBS-T. 
Afterwards, incubation with primary antibodies occurred overnight at 4°C. The 
following antibodies were dissolved in 1% NFDM in TBS-T, with the exception of 
anti-alix, which was dissolved only in TBS-T: 
Table 16: Primary antibodies used in Western blot analysis  
Antibody Host species Concentration used  Company 
actin mouse 0.3 µg/ml  Millipore 
alix mouse 1 µg/ml  Biozol 
calnexin rabbit 1 µg/ml  antibodies-online 
flotillin mouse 50 ng/ml  BD Bioscience 
lamin rabbit 0.5 µg/ml  Cell Signaling 
MHC class I H2 Kb rabbit 5 µg/ml  Abcam 
MHC II (I-A/I-E) rat 10 µg/ml  Millipore 
ovalbumin mouse 0.2 µg/ml  Sigma-Aldrich 
After three washing steps with TBS-T, membranes were incubated with 
HRP-coupled secondary antibodies in 0.83% NFDM in TBS-T for 1 h at room 
temperature. The following secondary antibodies were used: 
Table 17: Secondary antibodies used in Western blot analysis  
Antibody Host species Concentration used Company 
mouse goat 4 µg/ml Promega 
rabbit goat 4 µg/ml Promega 
rat goat 0.67 µg/ml Linaris 
After three washing steps as described above, membranes were incubated with ECL 
solution 1 and 2 in a ratio of 1:1. For signal detection, the LAS 2000 imaging 
system was used. To confirm equal protein loading, membranes were washed thrice 
in TBS-T, stripped using commercial stripping buffer, washed thrice again and 
incubation with primary antibodies (actin, lamin) was carried out as described 
above.  
Material and Methods 30 
 
3.2.8.3 Proteomic analysis 
The content of MPEK-derived exosomes was assessed by proteomic analysis. 
Proteins of purified exosomes were separated by one-dimensional SDS-PAGE and 
the gel was stained with Coomassie Brilliant Blue. Slices of the cut gel were 
reduced with 10 mM DTT, alkylated with 55 mM IAA for 20 min at 26°C, and 
digested with trypsin overnight at 37°C (Shevchenko et al. 1996). Tryptic peptides 
were injected onto a C18 pre-column to elute bound peptides. Thereafter, bound 
peptides were separated on a C18 capillary column using a nanoflow LC system 
coupled to an LTY-Orbitrap XL hybrid mass spectrometer using MS and MS/MS 
acquisition alternately. Raw data were analyzed with Mascot search engine against 
NCBI protein database for peptide and protein identifications. For annotation of 
acquired data, Scaffold (Proteome Software, Version 3.4) was applied with the 
following parameter settings: minimum peptide and protein identification 
probability 80% and minimum of 2 identified peptides per protein. As basis for 
analysis, every sample had to express the exosomal markers flotillin, alix, and 
tsg101. To be considered to be expressed at higher or lower levels, the respective 
protein had to be twice as much or half in comparison to medium control. 
Proteomic analysis was carried out by Prof. H. Urlaub, Bioanalytical Mass 
Spectrometry Group, Max Planck Institute for Biophysical Chemistry and 
Bioanalytics, Göttingen. 
3.2.9 Statistics 
Statistic data analysis was done using the rank-sum test with ANOVA-type 
statistics (Brunner et al. 2001). Data are visualized as means with error bars 





4.1 The murine kerationcyte cell line MPEK produces exosomes 
To address the question whether murine keratinocytes are able to produce 
exosomes, the MPEK cell line was cultivated and analyzed using a modified 
standard protocol for exosome purification (Thery et al. 2006). Supernatant of 
MPEK that had been treated with or without IFNγ (to imitate inflammatory 
conditions) was collected and after different centrifugation and filtration steps 
purified membrane vesicles of MPEK were obtained. Of interest, the quantity of 
produced exosomes by MPEK was comparable with and without IFNγ stimulation 
(Appendix table 28). Exosomes were analyzed with regard to their main 
characteristics: their size of 50-100 nm and their saucer-like shape in electron 
microscopy, their expression of exosomal markers like alix and flotillin in Western 
blot and proteomic analysis (Thery et al. 2009), and their density of 1.10-1.21 g/ml 
in sucrose gradients (Mathivanan et al. 2012). MPEK-derived membrane vesicles 
pictured in electron microscopy had a saucer-like shape and a diameter of 60-90 nm 
(Fig. 5a). The presence of the exosomal markers flotillin and alix and the absence of 
calnexin, a protein of the endoplasmic reticulum indicating contamination (Thery et 
al. 2006), were demonstrated by Western blot analysis (Fig. 5b). Moreover, these 
findings, as well as the presence of additional exosomal markers like tsg101 and 
CD81, were confirmed by proteomic analysis (Simpson et al. 2008) (Table 18). For 
further characterization, membrane vesicles were layered on a continuous sucrose 
gradient to determine the vesicle density. Analysis of the different density fractions 
by Western blot revealed the presence of flotillin at a density of 1.10 g/ml (Fig. 5c), 
consistent with exosomal content. Thus, with regard to shape, size, density, and 
expression of exosomal markers, MPEK-derived membrane vesicles meet all 





Figure 5: MPEK produce exosomes.  Analysis of MPEK-derived membrane vesicles with regard 
to exosome-defining traits. (a) Purified vesicles were visualized by electron microscopy picturing 
their saucer-like shape and size between 60-90 nm. Scale bar = 100 nm. (b) The presence of the 
exosomal markers alix and flotillin as well as the absence of the negative marker calnexin was 
detected by Western blot. 30 µg of lysate per sample were used for analysis of calnexin and flotillin 
and 40 µg for analysis of alix. Flotillin also served as loading control for calnexin. (c) Density 
analysis of the purified vesicles by means of sucrose gradient revealed the presence of flotillin in the 
fraction of 1.10 g/ml, compatible with exosomal density.  
 
Table 18: Exosomal markers detected by proteomic analysis 
Protein name Exosome Exosome IFNγ MW (kDa) Accession no. 
    alix + + 96 NP_001158150 
    calnexin -- --   
    CD80 + + 35 NP_033985 
    CD81 + + 18 NP_598416 
    flotillin-1 + + 48 NP_032053 




4.2 MPEK internalize antigen and shuttle it to their exosomes 
To assess whether MPEK are able to take up antigen and transfer it to their 
exosomes, the model antigen ovalbumin (OVA) was used. Keratinocytes were 
incubated with fluorescence labeled OVA at 4°C or 37°C to distinguish between 
unspecific binding and active antigen uptake, respectively. As demonstrated by 
fluorescence microscopy (Fig. 6a) and FACS analysis (Fig. 6b), MPEK incubated at 
37°C, unlike their counterparts incubated at 4°C, showed a strong fluorescence 
signal indicating active internalization of antigen. To assure antigen uptake and 
localization within the cell, OVA incubated MPEK were also analyzed by confocal 
microscopy confirming previous findings (Fig. 6c).  
Furthermore, uptake of pure OVA protein pictured by Western blot showed a 
doublet band at around 45 kDa that was also present when OVA incubated MPEK 
were analyzed (Fig. 6d). As exosomes contain membrane and cytosolic proteins of 
their cell of origin (Simpson et al. 2008), OVA internalized by MPEK should be 
transferred to MPEK-derived exosomes. Confirming this hypothesis, exosomes 
purified from OVA incubated MPEK showed a single band at 45 kDa in Western 
blot (Fig. 6e). When MPEK were stimulated with IFNγ prior to exosome 
purification, the OVA signal in Western blot was enhanced (for quantification, in 
densitometric analysis enhancement was more than threefold), suggesting an 





Figure 6: MPEK internalize OVA and shuttle it to their exosomes. To distinguish between active 
antigen uptake versus unspecific binding MPEK were incubated with FITC-labeled OVA (green) at 
4°C and 37°C as pictured by (a) fluorescence microscopy and (b) flow cytometry, respectively. 
20 µg/ml were used for analysis by fluorescence microscopy and 10 µg/ml for analysis by flow 
cytometry. In contrast to incubation at 4°C, incubation at 37°C led to a strong increase of 
fluorescence intensity suggesting active antigen uptake. For flow cytometry, only viable cells were 
taken into consideration. (c) Findings were confirmed by confocal microscopy demonstrating the 
presence of antigen (green) in OVA incubated MPEK. (d) Analysis by Western blot revealed the 
presence of OVA in lysates of antigen incubated MPEK, presenting the same doublet band as seen 
with pure OVA protein. 40 µg of MPEK lysate per sample were used. Actin served as loading 
control. (e) To demonstrate antigen transfer to MPEK exosomes, exosomes derived from OVA 
incubated MPEK were analyzed. Western blot demonstrates the presence of OVA in exosomes and 
even an enhanced signal intensity when additonal IFNγ stimulation of MPEK had occurred. 24 µg of 
lysate per exosome sample were used. Lamin served as loading control. 
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4.3 BMDC take up MPEK-derived exosomes with an increased 
quantity over time  
Dendritic cells function as professional APC. Depending on their phenotype, 
immature dendritic cells efficiently take up antigen, whereas mature dendritic cells 
mainly present it (Banchereau and Steinman 1998). BMDC generated in vitro were 
considered immature or semi-mature, prior to incubation with exosomes. In line 
with previous publications for BMDC exposed to DC-derived exosomes (Morelli et 
al. 2004), BMDC were able to internalize MPEK-derived exosomes as 
demonstrated by flow cytometry and immunofluorescence using PKH26-labeled 
exosomes (Fig. 7a and b). The time series of 0.5 h, 4 h, and 24 h of incubation 
demonstrated an increase of exosome internalization over time, however, showing 
strong interindividual differences between single BMDC. Since exosomes are too 
small to be visualized as individual particles by fluorescence microscopy, images 
depict aggregates of exosomes in a typical granular pattern (Fig. 7c) (Lin et al. 




Figure 7: Uptake of MPEK-derived exosomes by BMDC increases over time.  To visualize 
internalization of MPEK-derived exosomes by BMDC, BMDC had been incubated with 10 µg/ml 
PKH-labeled exosomes.  Uptake of MPEK-derived exosomes was analyzed after 0.5 min, 4 h, and 
24 h of incubation by (a) flow cytometry and (b) fluorescence microscopy, respectively. For flow 
cytometry only viable CD11c-positive cells were taken into consideration. (c) Amplification of 
BMDC in immunofluorescence after 4 h of incubation with exosomes revealed the typical granular 





4.4 Exosome-uptake enhances production of IL-6, IL-10, and 
IL-12 and CD40 expression by BMDC 
As BMDC were considered semi-mature before exosome incubation, the influence 
of exosome uptake on maturation was examined. Toward this end, BMDC where 
incubated for 24 h with different exosomes (Exo +/- IFNγ +/- OVA) and phenotype 
and interleukin profile were analyzed in vitro. Exosome uptake induced BMDC to 
produce higher amounts of IL-6, IL-10, and IL-12 as measured by ELISA (Fig. 8a). 
Importantly, incubation of BMDC with medium or OVA as controls did not show 
any comparable effects. In line with immunostimulatory potential of exosomes 
(Skokos et al. 2003), uptake led to maturation of BMDC as demonstrated by a 
significantly enhanced expression of CD40 compared to medium control. However, 
exosome internalization was not able to influence expression of CD86, MHC I, or 
MHC II (Fig. 8b). Overall, MPEK-derived exosomes showed a general 
immunostimulatory effect on BMDC, whereas no significant differences between 





Figure 8: Exosome-loaded BMDC increase IL-6, IL-10, and IL-12 production and CD40 
expression. To assess whether MPEK-derived exosomes have an impact on BMDC phenotype and 
interleukin profile, BMDC were incubated with 10 µg/ml of different loaded exosomes 
(Exo +/- OVA +/- IFNγ). Cytokine production and phenotype were analyzed by (a) ELISA and (b) 
flow cytometry, respectively. Interleukin production of IL-6, IL-10, and IL-12 was significantly 
enhanced, whereas with regard to phenotype only the expression of (b) CD40 but not of CD86, 
MHC I, or MHC II was increased. Only viable and CD11c-positive BMDC were analyzed 
phenotypically. There were no significant differences regarding the effects detected with different 
loaded exosomes. * indicates p < 0.05 compared to medium incubated BMDC. Statistical analysis 
was calculated with the rank-sum test with ANOVA-type statistic (Brunner et al. 2001), n = 5.  
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4.5 Antigen-containing exosomes fail to induce direct or 
BMDC-mediated antigen-specific T cell responses 
To assess whether exosomes deliver OVA protein unbound or its processed peptide 
derivates bound to MHC molecules, exosomal expression of MHC I and II was 
investigated by Western blot and proteomic analysis (Fig. 9a, Table 19). Western 
blot displayed the presence of MHC I in IFNγ stimulated as well as control 
(medium incubated) MPEK, whereas for exosomes, MHC I could only be detected 
in exosomes derived from IFNγ stimulated MPEK. Proteomic analysis of Exo and 
Exo IFNγ confirmed those findings with detection of H-2 class I histocompatibility 
antigen, L-D alpha chain precursor in samples of Exo IFNγ. No MHC II molecules 
could be detected in any preparations, neither of MPEK nor in any of their 
exosomes. This finding was irrespective of IFNγ stimulation. 
The question whether MPEK-derived exosomes would elicit antigen-specific T cell 
responses, was addressed by in vitro proliferation assays. Given that keratinocytes 
are non-professional APC, they express very few, if any, costimulatory molecules 
they could transfer to their exosomes (Nickoloff and Turka 1994). To compensate 
for this lack of molecules, co-culture experiments with BMDC were conducted. 
BMDC loaded with antigen-containing exosomes were incubated with CFSE 
stained CD4- or CD8-positive T cells derived from OT-I or OT-II mice, 
respectively. After a total of 72 h of co-culture, T cells were measured by flow 
cytometry for CFSE intensity and the supernatant was analyzed for IFNγ production 
(Fig. 9b and c). No significant changes of fluorescence or IFNγ production could be 
detected indicating that antigen-loaded exosomes failed to induce antigen-specific 
T cell responses. To test the hypothesis that exosomes could elicit T cell responses 
directly, antigen containing and, due to its pivotal role for immune responses, IFNγ 
stimulated exosomes (van Niel et al. 2003) were introduced into the same 
experimental set up and incubation with either CFSE stained CD4- or CD8-positive 
T cells was carried out (Fig. 9d). It was found that OVA-containing IFNγ stimulated 
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exosomes also failed to induce antigen-specific CD4 or CD8 T cell proliferation. 
All results were irrespective of additional T cell stimulation with IL-2.  
Table 19: MHC expression in MPEK-derived exosomes 
Protein name Exosome Exosome IFNγ MW (kDa) Accession no. 
H-2 class I histocompatibility    
antigen, L-D alpha chain  
precursor 
-- + 41 NP_034510 





        
Figure 9: Antigen-loaded exosomes failed to induce antigen-specific T cell response directly or 
via BMDC.  To analyze whether OVA protein is delivered unbound or bound to MHC molecules in 
exosomes, MHC I and MHC II expression of MPEK and their exosomes was analyzed by Western 
blot (a). Spleen lysate served as positive control. (b, c) For functional analysis, exosome-loaded 
BMDC were incubated for 72 h with antigen-specific T cells from OT-I or OT-II mice, respectively, 
and the T cell response was determined by (b) flow cytometry for proliferation and (c) by ELISA for 
IFNγ production. OVA-loaded BMDC and medium-incubated BMDC served as positive and 
negative controls, respectively. Analysis of a BMDC:T cell ratio of 1:3 is displayed. (d) Second, 
antigen-loaded IFNγ stimulated exosomes (10 µg/ml) were directly incubated with T cells, and 
proliferation was measured by flow cytometry. CD3/CD28 stimulated T cells and medium incubated 
T cells were used as positive and negative controls, respectively. For T cells to be taken into 
consideration, cells had to be viable, CD11c-negative, and CD4- or CD8-positive, respectively. Data 
are depicted as mean +/- standard deviation for triplicate cultures.  
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4.6 Composition of MPEK-derived exosomes is changed under 
defined conditions modeling clinical settings 
As shown before, exosomes were able to affect BMDC phenotype and interleukin 
production. To address the question whether environmental conditions were able to 
affect exosome composition, as demonstrated for IFNγ stimulation and MHC 
expression, MPEK were cultured under different conditions and their exosomes 
were analyzed by proteomic analysis. Skin diseases are known to affect the 
cytokine profile of keratinocytes in vivo, as it has been studied in various mouse 
models (Schön 2008; Spergel et al. 1998). In this experimental set up the cytokine 
environment of chronic skin diseases was simulated in vitro. In addition to the 
inflammatory stimulus IFNγ, the frequent chronic diseases psoriasis and atopic 
dermatitis display distinctly different patterns of inflammatory mediators. Based on 
this notion, MPEK were either incubated with IL-17, IL-22, and TNF-α as a typical 
cytokine profile of psoriasis (Raychaudhuri 2012) or with IL-4 and IL-13 
representative for atopic dermatitis (Bieber 2012). Exosomes generated under 
steady state conditions (medium) were analyzed for comparison. The following 
table (Table 20) presents an overview of proteins involved in adhesion, 
cytoskeleton, membrane fusion and transport, metabolism, antigen presentation, 
protein folding, and signaling. Proteins presented have been defined previously in 
exosomal preparations as presented in ExoCarta (Mathivanan and Simpson 2009).  
The results suggest a specific accumulation of proteins depending on specific 
conditions. In comparison to exosomes generated under steady state, influence of 








Table 20: Exosomal composition under different environmental conditions 












Cell adhesion       
basal cell adhesion 
molecule 
- + + ++ 68 EDL23193 
claudin-1 + + ++ + 23 NP_057883 
E-cadherine - - - + 98 P09803 
integrin α-6 + + + + 120 NP_032423 
 lactadherin/ milk fat 
globule-EGF factor 8 
+ + + + 47 NP_032620 
laminin B1 ++++++ + +++++ +++++ 202 AAA39407 
Cytoskeleton       
actin β + + + + 42 NP_001092 
actinin α 1 +++ + +++ +++ 103 NP_598917 
cofilin-1 + + + + 19 NP_031713 
filamin B - - - + 277 NP_598841 
keratin 13 type I + - - - 48 NP_034792 
Membrane fusion and transport       
alix/ programmed cell 
death 6-interacting 
protein 
+ + + + 96 NP_035182 
annexin A1 + + + + 39 NP_034860 
 
 




++ ++ ++ + 31 NP_034879 
rab 10 + + + + 23 NP_057885 
rab 14 + ++ ++ ++ 24 NP_080973 
Metabolic enzymes       
fatty acid synthase +++++ + ++++ ++++ 273 EDL34808 
glucose-6-phosphate 
isomerase 










+ + +(+) +(+) 40 NP_034829 
malate dehydrogenase 
1, cytoplasmic 





+ + + + 58 NP_035229 
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MHC molecules       
H-2 class I 
histocompatibility    
antigen, L-D alpha 
chain  
precursor 
- - - + 41 NP_034510 
MHC II - - - -   
Protein folding       
calreticulin precursor + + + + 48 NP_031617 
heat shock protein 90α ++++ + ++++ +++ 85 NP_034610 




+ + + + 57 NP_031978 
Signaling       
14-3-3 η ++ + ++ + 28 NP_035868 
14-3-3 σ 
 
+ + + + 28 NP_061224 
14-3-3 ε + + + + 29 NP_006752 
guaninenucleotide-
binding G(i) α2 
+ + + + 40 NP_032164 
major vault protein  ++ + ++ ++ 97 NP_542369 






5.1 Characterization of MPEK-derived membrane vesicles 
During the last decades, research on exosomes has focused on hematopoietic cells. 
Thus, little is known about epithelial cell-derived exosomes. In this work, it was 
demonstrated for the first time that murine keratinocytes produce exosomes under 
steady state as well as under inflammatory conditions (Figure 5 page 32). Before, 
exosome production had only been shown for human keratinocytes (Chavez-Muñoz 
et al. 2008) and other epithelial cells as intestinal epithelial cells (van Niel et al. 
2001). 
5.2  Immunological aspects of MPEK-derived exosomes  
5.2.1  MPEK-derived exosomes contain antigenic information 
Keratinocytes play a pivotal role in the cutaneous immune system. Besides their 
contribution to the innate immune system (Pivarcsi et al. 2005), they also take part 
in adaptive immune responses (Nickoloff and Turka 1994). To function as 
non-professional APC, keratinocytes have to take up antigen for presentation. 
Analysis by FACS and immunofluorescence microscopy demonstrated a strong 
increase of fluorescence when MPEK were incubated with FITC-labeled OVA at 
37°C whereas no change could be detected at 4°C. This dependence on temperature 
strongly suggests active antigen uptake instead of unspecific binding. Confocal 
microscopy and Western blot confirmed these results by demonstrating the presence 
of OVA via antibody reaction within the cell or cell lysate (Figure 6 page 34). 
Furthermore, these findings are in line with previous publications demonstrating not 
only the uptake, but also effective processing and presentation of antigen by 
keratinocytes (Black et al. 2007). As mentioned previously, exosomes contain a 
specific protein repertoire consisting of cytosolic and membrane proteins of their 
mother cell with a specific enrichment of certain proteins (Ratajczak et al. 2006; 
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Simpson et al. 2008). As a component of this molecular pattern, antigen 
internalized by MPEK was also transferred to their exosomes. As expected (Blume 
et al. 2009), increased allergen uptake by keratinocytes occurs under IFNγ 
stimulation. Lysates of MPEK-derived exosomes showed that their exosomes 
contained a higher quantity of antigen when MPEK had not only been exposed to 
the respective antigen but had been stimulated with IFNγ as well (Figure 6 page 
34).  
5.2.2  Immunostimulatory effect of MPEK-derived exosomes on BMDC  
Keratinocytes and DC, which are so-called Langerhans cells within the epidermis, 
maintain a close regional relationship to each other. In the experimental setting 
employed here, BMDC took up MPEK-derived exosomes as shown by fluorescence 
microscopy and FACS analysis (Figure 7 page 36). This finding is partially 
supported by previous publications, demonstrating BMDC to internalize 
DC-derived exosomes in vitro (Morelli et al. 2004). The uptake increased over 
time, with a strong inter-individual difference between particular cells (Figure 7 
page 36), a notion that is possibly associated with different states of maturation 
(Banchereau and Steinman 1998; Morelli et al. 2004).  
Keratinocytes are the most abundant cells within the skin. With their key role in the 
cutaneous immune system, they are able to directly kill or fight invading microbes 
through the production of antimicrobial peptides (AMP). However, they also link 
innate and adaptive immunity via AMP- and TLR-dependent activation of DC 
(Pivarcsi et al. 2005). Because keratinocytes are very numerous and are located 
adjacent to DC, it is conceivable that they “select” and transfer important 
information not only via AMP but also via their exosomes to regional DC, similar 
to the short range mechanism of exosomes of immature DC to spread alloantigen 
between DC (Montecalvo et al. 2008). This hypothesis is further supported by 
recent findings suggesting a specific uptake and target selection of exosomes via 
tetraspanins (Rana and Zoller 2011).  
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MPEK-derived exosomes were not only internalized by BMDC but their uptake 
also influenced BMDC phenotype and interleukin production, indicating an 
induction of maturation. DC maturation is crucial for the initiation of immune 
responses and is known to be induced by microbial products and certain cytokines 
as IL-1 or TNF-α in vivo (Banchereau and Steinman 1998). In vitro, internalized 
MPEK-derived exosomes induced BMDC to produce high amounts of IL-6, IL-10, 
and IL-12. Additionally, expression of the surface and maturation marker CD40 
was highly increased by uptake of MPEK-derived exosomes, whereas CD86, 
MHC I, or MHC II expression was not affected (Figure 8 page 38). Other studies 
demonstrated mast cell-derived exosomes to increase not only CD40 expression of 
BMDC, but also CD86 and MHC II expression (Skokos et al. 2003). In contrast, 
blood-borne exosomes did not affect splenic DC phenotype at all (IA
b
, CD54, 
CD86) (Morelli et al. 2004). Moreover, MPEK-derived exosomes altered the 
interleukin profile of BMDC. In recent experiments, a changed interleukin profile 
of macrophages through melanoma cell-derived exosomes has been demonstrated, 
which included induction of IL-8 and IL-1Ra but not of IL-6, IL-10, or IL-12. The 
observed cytokine profile could not be assigned in a strict sense to a TH1 or TH2 
type response (Marton et al. 2012). Further, trophoblast-derived exosomes were 
able to upregulate chemokine production of monocytes (amongst others IL-1β, IL-6, 
and TNFα) (Atay et al. 2010). However, even though MPEK-derived exosomes did 
influence BMDC phenotype and interleukin profile, this effect was comparable 
between the different kinds of exosomes (Exo +/- OVA +/- IFNγ). These findings 
emphasize two major points: the influence of exosomes strongly depends on the cell 
type of origin and MPEK-derived exosomes seem to have a general but not a 
specific immunostimulatory effect. With regard to the more complex in vivo 
situation, DCs are exposed to a multitude of exosomes derived from different cell 
types. Thus, changes of ratio between the different kinds of exosomes might be 
more relevant for DC maturation than the kind of exosome itself. 
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5.2.3 Antigen-specific functions of MPEK-derived exosomes 
MPEK-derived exosomes failed to induce an antigen-specific T cell response alone 
and via BMDC (Figure 9 page 41). This finding was somewhat surprising. Due to 
their shortage of co-stimulatory molecules only a couple of exosomes are able to 
elicit T cell responses directly (Admyre et al. 2006; Kovar et al. 2006). However, 
several studies have demonstrated that exosomes can stimulate T cells in the 
presence of APC (Andre et al. 2002; Andre et al. 2004).  
The failure of MPEK-derived exosomes to induce T cell proliferation via BMDC 
could be due to the décor of co-stimulatory molecules. Most experiments have been 
conducted with immune cell-derived exosomes. Immune cells, in comparison to 
keratinocytes, function as professional instead of non-professional APC and 
constitutively express a higher abundance of MHC and co-stimulatory molecules 
(Chavez-Muñoz et al. 2009; Segura et al. 2005b). However, intestinal epithelial 
cell-derived exosomes elicited a humoral immune response even though these 
exosomes were free of any co-stimulatory molecules. This study also emphasized 
the pivotal role of IFNγ, since only exosomes derived from IFNγ-stimulated cells 
were effective (van Niel et al. 2003). In line with our findings that MPEK did not 
express MHC II under IFNγ stimulation, this failure of expression has also been 
demonstrated for other murine keratinocytes in vitro before (Gaspari and Katz 
1988). However, transfer of MHC class II-restricted allopeptides to MHC class II 
molecules on the surface of APCs seems to be required (Montecalvo et al. 2008), 
suggesting the independence on MHC II expression of the exosomes’ mother cell. 
In addition, functional failure of too low antigen-loads could have been the reason 
for the lacking T cell proliferation. However, in vitro, DCs are able to elicit strong 
antigen-specific T cell responses with small antigen amount (nanomolar and 
picomolar concentrations) (Banchereau and Steinman 1998; Mellman et al. 1998). 
Exosomes can be internalized by two independent mechanisms. Either, they are 
taken up by the endocytic machinery or they directly fuse with the target cell’s 
membrane, releasing its content into the cytoplasm (Thery 2011). The way of 
internalization strongly influences the shuttle of antigen into different compartments 
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and, consequently, the processing and presentation of antigen (Hilmenyuk et al. 
2010). If keratinocyte exosomes are channeled into a different pathway than 
immune cell exosomes, it is conceivable that the differing effects are related to 
specific shuttle routes.  
However, it is also possible that MPEK-derived exosomes did not fail to induce 
antigen-specific T cell responses but rather prevented T cells from proliferation as 
an anti-inflammatory mechanism. Along this line of speculation, keratinocyte-
derived exosomes could exert protective functions, thus down-regulating excessive 
immune reactions. Indeed, serum-derived exosomes did prevent allergic 
sensitization in mice with allergic asthma (Almqvist et al. 2008). Interestingly, the 
immune-stimulating capacity of DC-derived exosomes significantly depends on the 
state of maturation. As mature DC-derived exosomes are considered the most potent 
immunostimulatory exosomes (Segura et al. 2005a; Zitvogel et al. 1998), immature 
DC-derived exosomes have immunosuppressive effects instead. The differential 
expression of co-stimulatory molecules is a possible explanation for this notion 
(Ruffner et al. 2009; Yin et al. 2013). However, with regards to their expression of 
co-stimulatory molecules, keratinocyte-derived exosomes are much more similar to 
immature DC-derived exosomes than to mature DC-derived ones (Chavez-Muñoz 
et al. 2009; Yin et al. 2013), suggesting an anti-inflammatory rather than a pro-
inflammatory immunological role. In vivo, this finding could imply an 
anti-inflammatory effect of keratinocyte-derived exosomes for physiological and 
pathological immune processes.  
5.3 Bidirectional entanglement of environmental conditions and 
exosomal composition 
Analysis of exosomes generated under the influence of “atopic” or “psoriatic” 
cytokine cocktails highlighted the profound environmental regulation of exosomal 
composition that affected virtually all functional fields (Table 20 page 43). 
Compared to primary keratinocytes, the use of a cell line provided more stability 
and reproducibility of the prepared exosomes, thus achieving better conditions to 
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compare the proteomic composition. Given that exosomes contain a distinctive 
assembly of proteins depending on the cell type they originate from (Simpson et al. 
2008), this specific fingerprint hints at the mother cell and/or its state of maturation, 
as demonstrated for dendritic cells and human keratinocytes (Chavez-Muñoz et al. 
2009; Yin et al. 2013). Therefore, it is possible to generate different exosomes by 
interleukin treatment of the mother cell. Exosomes of “conventional” 
monocyte-derived DC (MDDC) and IL-4/IL-3-generated MDDC phenotypically 
reflected their MDDC of origin (Johansson et al. 2008). However, a selective 
enrichment of proteins prevents exosomes from being a miniature format of the cell 
itself (Ratajczak et al. 2006). In line, investigations of exosomes derived of primary 
cancer cells and metastatic cells discovered selective enrichment of certain proteins 
involved in metastasis and signaling in metastatic cell-derived exosomes (Ji et al. 
2013). The specific protein composition of exosomes renders them as possible 
biomarkers. Especially in the fields of oncology and nephropathies, a lot of effort 
has been put on such biomarkers to improve early diagnosis and to predict the 
course of the disease (Dear et al. 2013; Simpson et al. 2009). Besides this 
diagnostic potential, exosomes may also provide therapeutic alternatives, as a 
variety of immunosuppressive exosomes for treating arthritis has been proposed 
(Yang and Robbins 2012). Moreover, IL-10 treatment of DC generated 
immunosuppressive exosomes, which were able to suppress inflammation and 
collagen-induced arthritis (Kim et al. 2005). Owing to their stability to phenotypic 
changes after injection, exosomes may qualify for therapeutic use (Zitvogel et al. 
1998). Contrariwise, exosomes may also provide a therapeutic target. 
Circumstantial evidence suggests that extracellular vesicles derived from 
Staphylococcus aureus are involved in the pathogenesis of atopic dermatitis (Hong 
et al. 2010). These findings are in line with a proinflammatory role of epithelial 
cell-derivd exosomes and further emphasize a pathophysiological role of exosomes 
in various diseases (Kulshreshtha et al. 2013). Thus, diminution of these vesicles is 
predicted to ameliorate certain disorders. The mutual influence of exosomes and the 
environment emphasizes the possible entanglement of exosomes in (patho)-
physiological processes and establishes a role for exosomes as potential therapeutic 
tools as well as targets.  
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5.4 Further considerations 
Notwithstanding the demonstration of new functions of murine keratinocyte-derived 
exosomes, this study has raised further questions and has some obvious limitations: 
 a) The BMDC and T cells used were generated for every experiment from different 
mice. Although the experimental animals were raised under identical conditions and 
were used at the same age, such biological systems may show considerable 
inter-individual variations.  
b) The experiments provided evidence for an immunomodulatory function of 
exosomes. Yet, it remains to be resolved whether keratinocyte-derived exosomes 
have a stimulatory or rather an immunosuppressive role in the cutaneous immune 
system and through which factors and pathways these effects are mediated. A 
feasible approach could be the demonstration of OVA in BMDC to exclude 
insufficient OVA transfer. Otherwise, it is not clear which quantity is needed to 
elicit an antigen-specific T cell response. Even if OVA would not have been 
visualized in BMDC, BMDC could still elicit a T cell response. Further, exosomes 
specifically influenced CD40 expression but not CD86, MHC I, or MHC II, thus 
strengthening the point of a specific response.  
c) Due to the lack of comparable mouse models and syngeneic DC in human 
models, the experimental setup cannot be transferred easily to human keratinocytes. 
However, the results would be supported by the demonstration of similar effects 
when using different murine cell lines and primary keratinocytes.  
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6 Summary and Conclusion 
Keratinocytes are able to influence cutaneous immunity by taking part in innate as 
well as in adaptive immune processes. To fulfill this task, the production of soluble 
factors has a key role. Exosomes, small membrane vesicles of endocytic origin and 
secreted by a variety of cells, may modify immune responses. However, little is 
known about the immunological function of keratinocyte-derived exosomes.  
To address this question, the murine keratinocyte cell line MPEK was cultured in 
vitro, and the production of exosomes has been demonstrated. These exosomes 
were internalized by bone marrow-derived dendritic cells (BMDC), where they 
induced production of high amounts of IL-6, IL-10, and IL-12 as well as increased 
surface expression of CD40. When MPEK were incubated with antigen, they 
transferred it to their exosomes. However, antigen-loaded exosomes failed to induce 
an antigen-specific T cell response directly or via BMDC. When environmental 
conditions, mimicked by cytokine cocktails characteristic for two of the most 
common chronic inflammatory skin disorders, atopic dermatitis or psoriasis, were 
modulated, a profound impact on the molecular repertoire of exosomes was found. 
The specifically altered components comprised virtually all functional fields. 
Even though MPEK-derived exosomes did not elicit an antigen-specific T cell 
response, they were clearly able to influence BMDC function and phenotype. 
Further, interleukins and IFNγ markedly influenced the molecular exosome 
composition. Together, these findings suggest an immunomodulatory function for 
MPEK-derived exosomes and a crucial effect of environmental conditions on 
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8.1 Supplemental data 
Table 21: CD40 MFI 




Exp: 1 634 - 1745 - 1627 775 
Exp: 2 554 1071 - 1352 1393 610 
Exp: 3 920 2962 2744 2558 2789 1103 
Exp: 4 850 1840 1912 1296 1231 852 
Exp: 5  478 1177 884 993 948 574 
 
Table 22: CD86 MFI 




Exp: 1 2136 - 4405 - 4116 2290 
Exp: 2 1807 1803 - 2175 2207 1657 
Exp: 3 1529 1755 1673 1462 1459 1486 
Exp: 4 2705 2736 2981 2955 2373 2742 
Exp: 5  2739 2078 2097 2101 2216 2457 
 
Table 23: MHC I MFI 




Exp: 1 347 - 401 - 364 352 
Exp: 2 396 471 - 515 503 434 
Exp: 3 655 769 667 708 567 674 
Exp: 4 551 483 519 436 426 552 




Table 24: MHC II MFI 




Exp: 1 1506 - 3319 - 3104 1684 
Exp: 2 7524 3265 - 4380 3568 6637 
Exp: 3 3525 3266 3064 2864 2242 4211 
Exp: 4 3365 2392 2350 2203 2124 4282 
Exp: 5  6384 3427 3585 3915 3823 6446 
 
Table 25: IL-6 pg/ml 




Exp: 1 94 - 196049 - 259927 388 
Exp: 2 55 67627 - 150508 190331 261 
Exp: 3 135 250644 305798 137684 262485 447 
Exp: 4 297 1398414 1586590 1605211 1626537 695 
Exp: 5  93 227987 204520 223765 270825 335 
 
Table 26: IL-10 pg/ml 




Exp: 1 0 - 1046 - 1013 0 
Exp: 2 0 403 - 786 709 0 
Exp: 3 0 154 249 64 153 0 
Exp: 4 0 147 200 309 271 0 






Table 27: IL-12 pg/ml 




Exp: 1 0 - 142 - 281 0 
Exp: 2 0 42 - 121 308 0 
Exp: 3 0 175 302 87 211 2 
Exp: 4 0 124 148 161 161 0 
Exp: 5  5 113 83 104 220 0 
 
Table 28: Exosome production µg/µl 
Exp 1 2 3 4 5 6 7 8 9 10 
Exo 1,05 1,70 3,00 1,00 0,28 0,30 0,54 0,54 0,98 0,80 




Kotzerke K, Mempel M, Aung T, Wulf GG, Urlaub H, Wenzel D, Schön MP, 
Braun A (2013): Immunostimulatory activity of murine keratinocyte-derived 
exosomes. Exp Dermatol 10, 650-655 
8.2.2 Presentations with published abstract 
Oral presentation and poster presentation at the 42
nd
 Annual ESDR Meeting in 
Venice and thus an abstract has been published: 
Kotzerke K, Aung T, Wulf GG, Urlaub H, Wenzel D, Schön MP, Mempel M, 
Braun A (2012): Immunostimulatory effects of exosomes from murine 
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